These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 30929102)

  • 1. 12-Month clinical results of drug-coated balloons for de novo coronary lesion in vessels exceeding 3.0 mm.
    Liu Y; Zhang YJ; Deng LX; Yin ZY; Hu T; Wang Q; Li Y; Li JY; Guo WY; Mou FJ; Tao L
    Int J Cardiovasc Imaging; 2019 Apr; 35(4):579-586. PubMed ID: 30929102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Follow-Up After Treatment of Drug-Eluting Stent Restenosis and De Novo Lesions Using SeQuent Please Paclitaxel-Coated Balloons.
    Zhang D; Sun Y; Liu X; Liu F; Cheng Y; Ma X; Zhao Y; Zhou Y
    Angiology; 2019 May; 70(5):414-422. PubMed ID: 30384776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fractional flow reserve-guided coronary angioplasty using paclitaxel-coated balloons without stent implantation: feasibility, safety and 6-month results by angiography and optical coherence tomography.
    Poerner TC; Duderstadt C; Goebel B; Kretzschmar D; Figulla HR; Otto S
    Clin Res Cardiol; 2017 Jan; 106(1):18-27. PubMed ID: 27379610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous coronary intervention for treating de-novo lesions in small coronary vessels: initial experience with the Essential paclitaxel-coated balloon.
    Abellas-Sequeiros RA; Benezet J; Agarrado Luna A; Oneto Otero J; Déry JP; Cieza T; DeLarochellière R; Duocastella L; Gomez A; Molina M; Asmarats L; Pelletier-Beaumont E; Puri R; Rodés-Cabau J
    Coron Artery Dis; 2018 Sep; 29(6):477-481. PubMed ID: 29621009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late clinical outcomes for SeQuent please paclitaxel-coated balloons in PCI of instent restenosis and de novo lesions: A single-center, real world registry.
    Hee L; Terluk A; Thomas L; Hopkins A; Juergens CP; Lo S; French JK; Mussap CJ
    Catheter Cardiovasc Interv; 2017 Feb; 89(3):375-382. PubMed ID: 27113534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of 2 Different Drug-Coated Balloons in In-Stent Restenosis: The RESTORE ISR China Randomized Trial.
    Chen Y; Gao L; Qin Q; Chen S; Zhang J; Chen H; Wang L; Jin Z; Zheng Y; Zhang Z; Li H; Li X; Fu G; Chen L; Sun Z; Wang Y; Jin Q; Cao F; Guo J; Zhao Y; Guan C; Li W; Xu B;
    JACC Cardiovasc Interv; 2018 Dec; 11(23):2368-2377. PubMed ID: 30522665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of large de novo coronary lesions with paclitaxel-coated balloon only: results from a Chinese institute.
    Yu X; Ji F; Xu F; Zhang W; Wang X; Lu D; Yang C; Wang F
    Clin Res Cardiol; 2019 Mar; 108(3):234-243. PubMed ID: 30074078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of Favorable Angiographic Outcomes After Drug-Coated Balloon Use for de novo Small Vessel Coronary Disease (DCB-ONLY).
    Kang WC; Park SM; Jang AY; Oh PC; Shin ES; Yu CW; Oh SJ; Kim YH; Won H; Lee SR; Lee SY; Hong YJ; Lee SY; Kim BO; Kim SW;
    Angiology; 2021 Nov; 72(10):986-993. PubMed ID: 33982603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes With Limus- vs Paclitaxel-Coated Balloons for Percutaneous Coronary Intervention: Meta-Analysis of Randomized Controlled Trials.
    Sedhom R; Hamed M; Elbadawi A; Mohsen A; Swamy P; Athar A; Bharadwaj AS; Prasad V; Elgendy IY; Alfonso F
    JACC Cardiovasc Interv; 2024 Jul; 17(13):1533-1543. PubMed ID: 38986653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-coated balloon angioplasty with provisional stenting versus primary stenting for the treatment of de novo coronary artery lesions: REC-CAGEFREE I trial rationale and design.
    Gao C; He X; Liu Y; Liu J; Jiang Z; Zhu B; Qin X; Xia Y; Zhang T; Wang P; Zhang R; Onuma Y; Xia J; Wang D; Serruys P; Tao L
    BMC Cardiovasc Disord; 2024 Jun; 24(1):319. PubMed ID: 38914951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-year results of a randomized comparison of XIENCE V everolimus-eluting and TAXUS paclitaxel-eluting stents: final results from the SPIRIT III trial (clinical evaluation of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions).
    Gada H; Kirtane AJ; Newman W; Sanz M; Hermiller JB; Mahaffey KW; Cutlip DE; Sudhir K; Hou L; Koo K; Stone GW
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1263-6. PubMed ID: 24239202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcome of titanium-nitride-oxide-coated cobalt-chromium stents in patients with de novo coronary lesions: 12-month results of the OPTIMAX first-in-man study.
    Karjalainen PP; Mikkelsson J; Paana T; Nammas W
    Catheter Cardiovasc Interv; 2016 Mar; 87(4):E122-7. PubMed ID: 26308878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of two different drug-coated balloons for the treatment of in-stent restenosis: A long-term single-centre experience.
    Benezet J; Agarrado A; Gutiérrez-Barrios A; Ruiz-Fernandez D; Del Río A; Cañadas D
    Cardiovasc Revasc Med; 2016; 17(3):176-80. PubMed ID: 26916568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-coated balloons for de novo lesions in small coronary arteries: rationale and design of BASKET-SMALL 2.
    Gilgen N; Farah A; Scheller B; Ohlow MA; Mangner N; Weilenmann D; Wöhrle J; Jamshidi P; Leibundgut G; Möbius-Winkler S; Zweiker R; Krackhardt F; Butter C; Bruch L; Kaiser C; Hoffmann A; Rickenbacher P; Mueller C; Stephan FP; Coslovsky M; Jeger R;
    Clin Cardiol; 2018 May; 41(5):569-575. PubMed ID: 29527709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Very Small De Novo Coronary Artery Disease With 2.0 mm Drug-Coated Balloons Showed 1-Year Clinical Outcome Comparable With 2.0 mm Drug-Eluting Stents.
    Sim HW; Ananthakrishna R; Chan SP; Low AF; Lee CH; Chan MY; Tay EL; Loh PH; Chan KH; Tan HC; Loh JP
    J Invasive Cardiol; 2018 Jul; 30(7):256-261. PubMed ID: 29656281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neointimal Modification With Scoring Balloon and Efficacy of Drug-Coated Balloon Therapy in Patients With Restenosis in Drug-Eluting Coronary Stents: A Randomized Controlled Trial.
    Kufner S; Joner M; Schneider S; Tölg R; Zrenner B; Repp J; Starkmann A; Xhepa E; Ibrahim T; Cassese S; Fusaro M; Ott I; Hengstenberg C; Schunkert H; Abdel-Wahab M; Laugwitz KL; Kastrati A; Byrne RA;
    JACC Cardiovasc Interv; 2017 Jul; 10(13):1332-1340. PubMed ID: 28683939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
    Dangas GD; Serruys PW; Kereiakes DJ; Hermiller J; Rizvi A; Newman W; Sudhir K; Smith RS; Cao S; Theodoropoulos K; Cutlip DE; Lansky AJ; Stone GW
    JACC Cardiovasc Interv; 2013 Sep; 6(9):914-22. PubMed ID: 24050859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compassionate use of a paclitaxel coated balloon in patients with refractory recurrent coronary in-stent restenosis.
    Clever YP; Cremers B; von Scheidt W; Böhm M; Speck U; Scheller B
    Clin Res Cardiol; 2014 Jan; 103(1):21-7. PubMed ID: 24072418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymer-free Biolimus A9-coated stents in the treatment of de novo coronary lesions with short DAPT: 9-month angiographic and clinical follow-up of the prospective, multicenter BioFreedom USA clinical trial.
    Waksman R; Piegari GN; Kabour A; Cannon L; Wang J; Adams G; Solankhi N; Smeglin A; Kereiakes DJ; Leiboff R; Spad MA; Torguson R; Chandra N; Bastian R; DeGroot J; Kayo MW; Stoll HP; Garcia-Garcia HM
    Cardiovasc Revasc Med; 2017; 18(7):475-481. PubMed ID: 28923692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of a biodegradable polymer Cobalt-Chromium sirolimus-eluting stent (EXCROSSAL) in treating de novo coronary artery disease: A pooled analysis of the CREDIT II and CREDIT III trials.
    Wang G; Wang H; Xu B; Yang Y; Yang Z; Li H; Zhang Z; Wang H; Yang L; Han Y
    Catheter Cardiovasc Interv; 2017 Mar; 89(S1):512-519. PubMed ID: 28112473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.